Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance

Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance

Histone modification is associated with resistance to anti-cancer drugs. Epigenetic modifications of histones can regulate resistance to anti-cancer drugs. It has been reported that histone deacetylase 3 (HDAC3) regulates responses to anti-cancer drugs, angiogenic potential, and tumorigenic potentia...

Full description

Bibliographic Details
Main Authors:	Yoojung Kwon, Youngmi Kim, Hyun Suk Jung, Dooil Jeoung
Format:	Article
Language:	English
Published:	MDPI AG 2018-12-01
Series:	International Journal of Molecular Sciences
Subjects:	anti-cancer drug-resistance histone deacetylase-3 cancer/testis antigen CAGE epidermal growth factor receptor micro RNAs molecular network
Online Access:	http://www.mdpi.com/1422-0067/20/1/51

Similar Items

The hyaluronic acid-HDAC3-miRNA network in allergic inflammation
by: Youngmi eKim, et al.
Published: (2015-04-01)

CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells
by: Minjeong Yeon, et al.
Published: (2018-12-01)

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
by: Donglu Wu, et al.
Published: (2020-11-01)

Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages
by: Yoojung Kwon, et al.
Published: (2020-06-01)

Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
by: Robert Jenke, et al.
Published: (2021-02-01)

HDAC-Linked “Proliferative” miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors
by: Eckhard Klieser, et al.
Published: (2018-09-01)

The Role of HDACs as Leukemia Therapy Targets using HDI
by: Ahmad Ahmadzadeh, et al.
Published: (2016-02-01)

Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
by: Debarati Banik, et al.
Published: (2019-05-01)

The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
by: Shalome A. Bassett, et al.
Published: (2014-10-01)

CAGE-miR-140-5p-Wnt1 Axis Regulates Autophagic Flux, Tumorigenic Potential of Mouse Colon Cancer Cells and Cellular Interactions Mediated by Exosomes
by: Minjeong Yeon, et al.
Published: (2019-11-01)

Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells
by: Yoojin Song, et al.
Published: (2020-01-01)

Contribution à létude du rôle des déacétylases dhistones HDAC4 et HDAC8 dans la biologie des cellules de phénotype musculaire lisse
by: Glénisson, Wendy
Published: (2007)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors
by: Nils Goehringer, et al.
Published: (2021-08-01)

Effects of novel HDAC inhibitors on urothelial carcinoma cells
by: Aline Kaletsch, et al.
Published: (2018-07-01)

The Role of Epigenetics on Dental Implant Therapy: A Systematic Review
by: Riccardo Di Gianfilippo, et al.
Published: (2017-08-01)

Epigenetic Therapy in Lung Cancer
by: Stephen V Liu, et al.
Published: (2013-05-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Aberrant HDAC3 expression correlates with brain metastasis in breast cancer patients
by: Li Ma, et al.
Published: (2020-09-01)

The Cancer/Testis Antigen Gene VCX2 Is Rarely Expressed in Malignancies but Can Be Epigenetically Activated Using DNA Methyltransferase and Histone Deacetylase Inhibitors
by: Mie K. Jakobsen, et al.
Published: (2021-02-01)

Osthole extracted from a citrus fruit that affects apoptosis on A549 cell line by histone deacetylasese inhibition (HDACs)
by: Hamed A. Abosharaf, et al.
Published: (2020-12-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
by: Saikat Dewanjee, et al.
Published: (2021-05-01)

HDAC3 and HDAC8 are required for cilia assembly and elongation
by: Seon-ah Park, et al.
Published: (2019-08-01)

MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer
by: Q.D. Mao, et al.

The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
by: Maria Cosenza, et al.
Published: (2018-08-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
by: Zhu Y, et al.
Published: (2019-12-01)

Phytochemical Modulation of MiRNAs in Colorectal Cancer
by: Aravinda Ganapathy, et al.
Published: (2019-04-01)

HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
by: Jasmina Makarević, et al.
Published: (2018-09-01)

Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers
by: Aurélien Linares, et al.
Published: (2019-07-01)

Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast‐derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation
by: Kenny Man, et al.
Published: (2021-07-01)

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
by: Pushkar Singh Rawat, et al.
Published: (2021-07-01)

Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents
by: Subhasish Tapadar, et al.
Published: (2020-10-01)

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
by: Amila Suraweera, et al.
Published: (2018-03-01)

Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
by: Amit Kumar Singh, et al.
Published: (2018-06-01)

Mechanism of Action for HDAC Inhibitors—Insights from Omics Approaches
by: Wenbo Li, et al.
Published: (2019-04-01)

The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma
by: Fang Wang, et al.
Published: (2021-03-01)

Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
by: Jun Sheng Wong, et al.
Published: (2020-07-01)

Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
by: Jagoda K Wrobel, et al.
Published: (2020-10-01)